Keysight director awarded 870 RSU shares
CULLEN JAMES reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CULLEN JAMES reported acquisition or exercise transactions in this Form 4 filing.
Keysight Technologies director James Cullen received 870 shares of common stock as a restricted stock unit (RSU) award. The RSUs, granted under the 2014 Equity and Incentive Compensation Plan, vested immediately. Following this compensation-related grant, Cullen directly holds a total of 24,821 shares of Keysight common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 870 | $0.00 | $0.00 |
Footnotes (1)
- F1. Common stock underlying restricted stock units ("RSUs") granted pursuant to the 2014 Equity and Incentive Compensation Plan. The RSUs vested immediately.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Keysight (KEYS) director James Cullen report in this Form 4?
Was James Cullen’s Keysight (KEYS) Form 4 transaction a market purchase or sale?
What type of equity award did Keysight (KEYS) grant to director James Cullen?
Does the Keysight (KEYS) Form 4 indicate any derivative securities for James Cullen?
AI-generated analysis. How Rhea-AI works. Not financial advice.